Blueprint Medicines Corp Cash Flow Reinvestment Rate
Blueprint Medicines Corp cash flow reinvestment rate. Blueprint Medicines Corp (BPMC) has a Cash Flow Reinvestment Rate of 0.69x as of September 2020, reinvesting $430.14 Million (capex $6.00K plus investments $-430.13 Million) from operating cash flow of $622.33 Million. See BPMC financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Blueprint Medicines Corp (2020–2020)
Cash flow reinvestment rate of Blueprint Medicines Corp from 2020 to 2020. Historical reinvestment intensity for Blueprint Medicines Corp across 1 annual periods. Explore Blueprint Medicines Corp cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Blueprint Medicines Corp Cash Flow Reinvestment Rate by Year (2020–2020)
Blueprint Medicines Corp cash flow reinvestment rate by year from 2020 to 2020. Year-by-year capital reinvestment analysis for Blueprint Medicines Corp. For the full cash flow conversion analysis, see Blueprint Medicines Corp cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 1.12x | $434.25 Million | $387.04 Million | $3.16 Million | — |